Syndax Pharmaceuticals Inc (SNDX)
Sales/Maturities of Investments
$394.53M
TTM · Period ending: · USD
SNDX Sales/Maturities of Investments
Latest reported$394.53Mperiod ending
Latest reported$394.53Mperiod ending
SNDX TTM Sales/Maturities of Investments ($0.00 → $394.53M)
TTM Sales/Maturities of Investments
High-resolution chart · PNG
SNDX sales/maturities of investments history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 394,527,000 | |
| 459,127,000 | |
| 486,030,000 | |
| 448,621,000 | |
| 445,821,000 | |
| 373,971,000 | |
| 337,277,000 | |
| 342,936,000 | |
| 365,536,000 | |
| 458,701,000 | |
| 472,215,000 | |
| 472,465,000 | |
| 422,482,000 | |
| 339,985,000 | |
| 308,933,000 | |
| 241,083,000 | |
| 257,841,000 | |
| 266,923,000 | |
| 253,975,000 | |
| 273,022,000 | |
| 221,947,000 | |
| 158,022,000 | |
| 136,407,000 | |
| 113,682,000 | |
| 96,544,000 | |
| 99,304,000 | |
| 116,799,000 | |
| 109,756,000 | |
| 117,894,000 | |
| 139,309,000 | |
| 130,429,000 | |
| 136,593,000 | |
| 139,078,000 | |
| 134,680,000 | |
| 135,275,000 | |
| 142,327,000 | |
| 140,367,000 | |
| 133,535,000 | |
| 140,297,000 | |
| 108,279,000 | |
| 97,538,000 | |
| 70,283,000 | |
| 40,506,000 | |
| 24,629,000 | |
| 5,345,000 | |
| 4,616,000 | |
| 5,286,000 | |
| 5,286,000 | |
| 5,286,000 | |
| 2,750,000 | |
| 0 | |
| 0 |